Compare ANIX & CNTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ANIX | CNTY |
|---|---|---|
| Founded | 1982 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 114.0M | 36.0M |
| IPO Year | 2013 | 1996 |
| Metric | ANIX | CNTY |
|---|---|---|
| Price | $2.76 | $1.15 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $8.67 | $3.00 |
| AVG Volume (30 Days) | ★ 321.5K | 31.1K |
| Earning Date | 05-27-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 12.82 | ★ 51.31 |
| EPS | ★ N/A | N/A |
| Revenue | $210,000.00 | ★ $430,529,000.00 |
| Revenue This Year | N/A | $7.17 |
| Revenue Next Year | N/A | $3.28 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 10.82 |
| 52 Week Low | $2.32 | $1.14 |
| 52 Week High | $5.46 | $2.80 |
| Indicator | ANIX | CNTY |
|---|---|---|
| Relative Strength Index (RSI) | 29.89 | 34.61 |
| Support Level | $2.37 | N/A |
| Resistance Level | $3.09 | $1.33 |
| Average True Range (ATR) | 0.19 | 0.03 |
| MACD | -0.06 | -0.01 |
| Stochastic Oscillator | 9.01 | 12.50 |
Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer Vaccines segment involves vaccines to treat and prevent breast and ovarian cancer, as well as additional cancer vaccines targeting intractable cancers, including high-incidence malignancies in lung, colon, and prostate. The CAR-T Therapies segment involves the development of liraltagene autoleucel (lira-cel), an ovarian cancer immunotherapy using chimeric endocrine receptor-T cell technology, developed at its subsidiary, Certainty Therapeutics, Inc. The Other segment consists of legacy operations, including limited patent licensing activities.
Century Casinos Inc is a casino entertainment company that develops and operates gaming establishments as well as related lodging, restaurants, horse racing (including off-track betting), and entertainment facilities in North America. The company has five reportable segments based on the geographical locations in which its casinos operate; US East, US Midwest, US West, Canada, and Poland.